{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T06:23:59Z","timestamp":1795242239040,"version":"4.10.3"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijantimicag.2026.107764","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:43:39Z","timestamp":1772264619000},"page":"107764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Present trajectories to forecasted future: A longitudinal analysis of hospital antibiotic use in China from 2013 to 2024 and projections to 2030"],"prefix":"10.1016","volume":"67","author":[{"given":"Weibin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenqi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruowei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihsin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suriguga","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1290-3827","authenticated-orcid":false,"given":"Xiaodong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haishaerjiang","family":"Wushouer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107764_bib0001","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0002","series-title":"2023 antibacterial agents in clinical and preclinical development: an overview and analysis","year":"2024"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0003","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2411919121","article-title":"Global trends in antibiotic consumption during 2016-2023 and future projections through 2030","volume":"121","author":"Klein","year":"2024","journal-title":"Proc Natl Acad Sci United States of America"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0004","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cmi.2022.03.014","article-title":"Exposure to World Health Organization\u2019s AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis","volume":"28","author":"Sulis","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0005","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/pharmaceutics15020518","article-title":"Correlation between Antimicrobial resistance and the hospital-wide diverse use of broad-spectrum antibiotics by the Antimicrobial Stewardship Program in Japan","volume":"15","author":"Ueda","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0006","first-page":"388","article-title":"Current state and development of antibacterial surveillance in China","volume":"9","author":"Yang","year":"2016","journal-title":"Chin J Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0007","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2471\/BLT.22.288862","article-title":"Inpatient antibacterial use trends and patterns, China, 2013-2021","volume":"101","author":"Wushouer","year":"2023","journal-title":"Bullet World Health Organization"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0008","series-title":"The selection and use of essential medicines 2023: web annex C: WHO AWaRe (access, watch, reserve) classification of antibiotics for evaluation and monitoring of use, 2023","year":"2023"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0009","unstructured":"Norwegian Institute of Public Health.\u00b7ATC\/DDD index 2025\u00b7(accessed 16 October 2025)\u00b7https:\/\/atcddd.fhi.no\/atc_ddd_index\/"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1467-9868.2008.00700.x","article-title":"Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations","volume":"71","author":"Rue","year":"2009","journal-title":"J Royal Stat Soc Series B"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0011","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cmi.2024.12.005","article-title":"Trends in antimicrobial consumption: long-term impact of the COVID-19 pandemic","volume":"31","author":"Tsuzuki","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0012","doi-asserted-by":"crossref","first-page":"106339","DOI":"10.1016\/j.ijantimicag.2021.106339","article-title":"Outpatient antibiotic use attributable to viral acute lower respiratory tract infections during the cold season in France, 2010-2017","volume":"57","author":"Cheysson","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0013","unstructured":"Ministry of Health, People's Republic of China. Administrative regulations for clinical use of antibacterial agents\u00b7(accessed 7 May 2025)\u00b7https:\/\/www.gov.cn\/flfg\/2012-05\/08\/content_2132174.htm"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0014","unstructured":"Office of the National Health and Family Planning Commission, Office of the State Administration of Traditional Chinese Medicine. Notice on further strengthening the management of antibacterial drug clinical application\u00b7(accessed 7 May 2025)\u00b7https:\/\/www.gov.cn\/xinwen\/2015-08\/27\/content_2920789.htm"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0015","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1473-3099(20)30596-X","article-title":"Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study","volume":"21","author":"Zhao","year":"2021","journal-title":"The Lancet. Infectious Diseases"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0016","unstructured":"Ministry of Health, People's Republic of China. Notice of the General Office of the Ministry of Health on launching the national campaign for the clinical application of antimicrobial agents. (accessed 16 October 2025) https:\/\/www.nhc.gov.cn\/zwgkzt\/wsbysj\/201104\/51376.shtml"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0017","first-page":"1496","article-title":"Analysis of concentration and similarity of antimicrobial agent use in China","volume":"33","author":"Yu","year":"2024","journal-title":"Chinese J. New Drugs"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0018","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s44280-025-00092-0","article-title":"Antimicrobial resistance profile of clinical isolates from hospitals across China: CHINET 2024 surveillance report","volume":"3","author":"Guo","year":"2025","journal-title":"One Health Advances"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0019","first-page":"2945","article-title":"Comparative analysis of domestic classification management list for clinical use of antibiotics versus WHO AWaRe classification list of antibiotics","volume":"33","author":"Yang","year":"2022","journal-title":"China Pharmacy"},{"key":"10.1016\/j.ijantimicag.2026.107764_bib0020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cmi.2022.12.011","article-title":"A comparative study of antibiotic use in China under Chinese restriction list and world health organization AWaRe classification","volume":"29","author":"Wushouer","year":"2023","journal-title":"Clin Microbiol Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:03:19Z","timestamp":1785754999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926000531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0924857926000531"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107764","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Present trajectories to forecasted future: A longitudinal analysis of hospital antibiotic use in China from 2013 to 2024 and projections to 2030","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107764"}}